GlassScriptPhysician profile
David Albert Sterns
NPI 1154382141
$27,598.29
in general payments reported to CMS, 2019-2025
36 companies · $3,105 in 2025
The $3,105 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,996 · 2020: $3,049 · 2021: $4,956 · 2022: $8,427 · 2023: $3,904 · 2024: $2,161 · 2025: $3,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,630 · Travel and Lodging: $2,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,630.30 |
| Travel and Lodging | $2,540.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23,123.50 | 2019-2025 | Aveir, Assurity, Quadra Assura |
| Novartis Pharmaceuticals Corporation | $538.50 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $407.73 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $388.59 | 2019-2025 | Lifevest |
| Amgen INC. | $351.30 | 2019-2023 | Repatha |
| Boston Scientific Corporation | $286.43 | 2019-2024 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $234.08 | 2023-2025 | Micra, Azure Xt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $210.30 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $210.24 | 2020-2024 | Xarelto |
| Pfizer INC. | $202.60 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $199.60 | 2019-2024 | Wainua |
| Scpharmaceuticals INC. | $171.84 | 2023-2024 | |
| Medicure Pharma INC. | $158.82 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $142.66 | 2019-2022 | |
| Abbvie INC. | $121.61 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $114.00 | 2021-2024 | Nexletol |
| Amarin Pharma, INC. | $103.38 | 2020-2021 | |
| Medtronic Vascular, INC. | $100.51 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.10 | 2022-2025 | Jardiance |
| Irhythm Technologies, INC. | $66.03 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $43.75 | 2022-2024 | Verquvo |
| Philips North America LLC | $37.29 | 2023-2024 | (5044) Mcot |
| Itamar Medical INC | $34.51 | 2022 | |
| Impulse Dynamics (USA) INC. | $33.63 | 2022 | |
| Cardiva Medical, INC. | $30.82 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Baxter Healthcare | $26.18 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $23.15 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Jazz Pharmaceuticals INC. | $21.49 | 2024 | |
| Zimmer Biomet Holdings, INC. | $19.58 | 2020 | |
| Grifols USA, LLC | $19.54 | 2023 | Prolastin-C Liquid |
| Novo Nordisk INC | $17.97 | 2025 | Wegovy |
| Harmony Biosciences LLC | $17.90 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $17.80 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $16.35 | 2023 | |
| Alnylam Pharmaceuticals INC. | $15.33 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $13.18 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sterns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.